A Clinicobiological Database in Metastatic Digestive Cancers

Recruiting now · Not applicable

Conditions studied: Digestive System Neoplasm

In brief

Creation of a collection of blood samples that will be collected before and then under treatment in patients with digestive adenocarcinoma during the 1st and 2nd metastatic line and which, depending on scientific progress, can be used for research projects aimed at developing tailored patient management strategies.

Key facts

Study ID

NCT03978078

Run by

Institut du Cancer de Montpellier - Val d'Aurelle

People needed

200

Starts

2016-09-12

Expected to finish

2031-09-01

Last updated by the study team

2025-02-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female ≥ 18 years old
• Histological documentation of adenocarcinoma of the colon or rectum, small intestine, pancreas, stomach, bile duct, oesophagus
• Patient who will receive a first or second line metastatic chemotherapy and/or targeted therapy
• Informed consent form (ICF) signed

You may not qualify if…

• Male or female < 18 years old
• Non-adenocarcinoma histological type
• Patient already undergoing specific treatment (chemotherapy and/or targeted therapy) in 1st or 2nd metastatic line
• Pregnant and/or breastfeeding woman
• Patient not affiliated to a social security system
• Patient whose regular follow-up is impossible for psychological, family, social or geographical reasons
• Patient who is included in a Phase I-II therapeutic trial modifying usual management and involving additional and specific blood samples

Where it is running

• Institut régional du cancer de Montpellier — Montpellier, Hérault, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.